Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis
- PMID: 30341437
- DOI: 10.1038/s41584-018-0109-2
Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by a failure of spontaneous resolution of inflammation. Although the pro-inflammatory cytokines and mediators that trigger RA have been the focus of intense investigations, the regulatory and anti-inflammatory cytokines responsible for the suppression and resolution of disease in a context-dependent manner have been less well characterized. However, knowledge of the pathways that control the suppression and resolution of inflammation in RA is clinically relevant and conceptually important for understanding the pathophysiology of the disease and for the development of treatments that enable long-term remission. Cytokine-mediated processes such as the activation of T helper 2 cells by IL-4 and IL-13, the resolution of inflammation by IL-9, IL-5-induced eosinophil expansion, IL-33-mediated macrophage polarization, the production of IL-10 by regulatory B cells and IL-27-mediated suppression of lymphoid follicle formation are all involved in governing the regulation and resolution of inflammation in RA. By better understanding these immune-regulatory signalling pathways, new therapeutic strategies for RA can be envisioned that aim to balance and resolve, rather than suppress, inflammation.
Similar articles
-
Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.Cytokine. 2017 Oct;98:87-96. doi: 10.1016/j.cyto.2017.04.012. Epub 2017 Apr 25. Cytokine. 2017. PMID: 28438552 Free PMC article. Review.
-
Suppression of inflammation and joint destruction in rheumatoid arthritis may require a concerted action of Th2 cytokines.Curr Opin Investig Drugs. 2002 Jul;3(7):1011-6. Curr Opin Investig Drugs. 2002. PMID: 12186260 Review.
-
In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis.J Immunol. 2016 Sep 1;197(5):1708-19. doi: 10.4049/jimmunol.1502124. Epub 2016 Jul 29. J Immunol. 2016. PMID: 27474075
-
Emerging Role of Eosinophils in Resolution of Arthritis.Front Immunol. 2021 Oct 18;12:764825. doi: 10.3389/fimmu.2021.764825. eCollection 2021. Front Immunol. 2021. PMID: 34733292 Free PMC article. Review.
-
[Rheumatoid arthritis and cytokines].Nihon Rinsho. 2016 Jun;74(6):913-8. Nihon Rinsho. 2016. PMID: 27311178 Review. Japanese.
Cited by
-
Clinical Evaluation of Collagen-Induced Arthritis in Female Lewis Rats: A Comprehensive Analysis of Disease Progression and Severity.Cell J. 2023 Dec 31;25(12):854-862. doi: 10.22074/cellj.2023.2004504.1326. Cell J. 2023. PMID: 38192256 Free PMC article.
-
Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases.J Histochem Cytochem. 2020 Dec;68(12):887-906. doi: 10.1369/0022155420930303. Epub 2020 Jul 6. J Histochem Cytochem. 2020. PMID: 32623933 Free PMC article. Review.
-
Network-Based In Silico Analysis of New Combinations of Modern Drug Targets with Methotrexate for Response-Based Treatment of Rheumatoid Arthritis.J Pers Med. 2023 Oct 29;13(11):1550. doi: 10.3390/jpm13111550. J Pers Med. 2023. PMID: 38003865 Free PMC article. Review.
-
Microbe-Derived Antioxidants Reduce Lipopolysaccharide-Induced Inflammatory Responses by Activating the Nrf2 Pathway to Inhibit the ROS/NLRP3/IL-1β Signaling Pathway.Int J Mol Sci. 2022 Oct 18;23(20):12477. doi: 10.3390/ijms232012477. Int J Mol Sci. 2022. PMID: 36293333 Free PMC article.
-
Punicalagin Inhibited Inflammation and Migration of Fibroblast-Like Synoviocytes Through NF-κB Pathway in the Experimental Study of Rheumatoid Arthritis.J Inflamm Res. 2021 May 12;14:1901-1913. doi: 10.2147/JIR.S302929. eCollection 2021. J Inflamm Res. 2021. PMID: 34012288 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical